ES2337852T3 - Metodos y dispositivos para la eliminacion de psoralenos de productos sanguineos. - Google Patents

Metodos y dispositivos para la eliminacion de psoralenos de productos sanguineos. Download PDF

Info

Publication number
ES2337852T3
ES2337852T3 ES96921456T ES96921456T ES2337852T3 ES 2337852 T3 ES2337852 T3 ES 2337852T3 ES 96921456 T ES96921456 T ES 96921456T ES 96921456 T ES96921456 T ES 96921456T ES 2337852 T3 ES2337852 T3 ES 2337852T3
Authority
ES
Spain
Prior art keywords
psoralen
blood
resin
blood product
container
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96921456T
Other languages
English (en)
Spanish (es)
Inventor
Derek J. Hei
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cerus Corp
Original Assignee
Cerus Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cerus Corp filed Critical Cerus Corp
Priority claimed from US08/659,249 external-priority patent/US6544727B1/en
Application granted granted Critical
Publication of ES2337852T3 publication Critical patent/ES2337852T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B27/00—Layered products comprising a layer of synthetic resin
    • B32B27/12—Layered products comprising a layer of synthetic resin next to a fibrous or filamentary layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/19—Platelets; Megacaryocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/08—Radiation
    • A61L2/081—Gamma radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
    • A61M1/3683—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation using photoactive agents
    • A61M1/3686—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation using photoactive agents by removing photoactive agents after irradiation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B27/00—Layered products comprising a layer of synthetic resin
    • B32B27/36—Layered products comprising a layer of synthetic resin comprising polyesters
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B5/00—Layered products characterised by the non- homogeneity or physical structure, i.e. comprising a fibrous, filamentary, particulate or foam layer; Layered products characterised by having a layer differing constitutionally or physically in different parts
    • B32B5/02—Layered products characterised by the non- homogeneity or physical structure, i.e. comprising a fibrous, filamentary, particulate or foam layer; Layered products characterised by having a layer differing constitutionally or physically in different parts characterised by structural features of a fibrous or filamentary layer
    • B32B5/028—Net structure, e.g. spaced apart filaments bonded at the crossing points
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B2367/00—Polyesters, e.g. PET, i.e. polyethylene terephthalate
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B2439/00—Containers; Receptacles
    • B32B2439/80—Medical packaging

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Compounds Of Unknown Constitution (AREA)
ES96921456T 1995-06-07 1996-06-07 Metodos y dispositivos para la eliminacion de psoralenos de productos sanguineos. Expired - Lifetime ES2337852T3 (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US48492695A 1995-06-07 1995-06-07
US484926 1995-06-07
US66091096A 1996-06-07 1996-06-07
PCT/US1996/009846 WO1996040857A1 (en) 1995-06-07 1996-06-07 Methods and devices for the removal of psoralens from blood products
US08/659,249 US6544727B1 (en) 1995-06-07 1996-06-07 Methods and devices for the removal of psoralens from blood products

Publications (1)

Publication Number Publication Date
ES2337852T3 true ES2337852T3 (es) 2010-04-29

Family

ID=29740870

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96921456T Expired - Lifetime ES2337852T3 (es) 1995-06-07 1996-06-07 Metodos y dispositivos para la eliminacion de psoralenos de productos sanguineos.

Country Status (8)

Country Link
EP (1) EP0840781B1 (https=)
JP (1) JP4968974B2 (https=)
AT (1) ATE451445T1 (https=)
AU (1) AU6267796A (https=)
CA (1) CA2221605C (https=)
DE (1) DE69638094D1 (https=)
ES (1) ES2337852T3 (https=)
WO (1) WO1996040857A1 (https=)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0773716A4 (en) * 1995-06-07 1999-08-04 Cerus Corp TREATMENT OF RED BLOOD CELL SOLUTIONS WITH ANTIVRAL ACTIVE SUBSTANCES
JP2009051846A (ja) * 1995-06-07 2009-03-12 Cerus Corp 血液製剤からソラレンを除去するための方法およびデバイス
DE19544297A1 (de) * 1995-11-28 1997-06-05 Behringwerke Ag Verfahren zur Entfernung von aromatischen Verbindungen aus produkthaltigen Lösungen
WO1997037536A1 (en) * 1996-04-09 1997-10-16 Therakos, Inc. Method for removal of psoralens from biological fluids
AU6021698A (en) * 1997-01-06 1998-08-03 Cerus Corporation Methods and devices for the reduction of small organic compounds from bloo d products
US6093725A (en) * 1997-01-06 2000-07-25 Cerus Corporation Frangible compounds for pathogen inactivation
US20010009756A1 (en) 1998-01-06 2001-07-26 Derek Hei Flow devices for the reduction of compounds from biological compositions and methods of use
US6514987B1 (en) 1997-01-06 2003-02-04 Cerus Corporation Frangible compounds for pathogen inactivation
US20010018179A1 (en) 1998-01-06 2001-08-30 Derek J. Hei Batch devices for the reduction of compounds from biological compositions containing cells and methods of use
CN1203900C (zh) 1998-01-06 2005-06-01 塞鲁斯公司 用于淬灭生物材料中病原体灭活剂的方法
US7611831B2 (en) 1998-01-06 2009-11-03 Cerus Corporation Adsorbing pathogen-inactivating compounds with porous particles immobilized in a matrix
US6403359B1 (en) 1998-09-25 2002-06-11 V. I. TECHNOLOGIES, Inc. Solid phase quenching systems
US6617100B2 (en) * 1998-09-25 2003-09-09 V.I. Technologies, Inc. Solid phase quenching systems
US6364864B1 (en) 1999-06-03 2002-04-02 Baxter International Inc. Plastic containers having inner pouches and methods for making such containers
US7025877B1 (en) 1999-06-03 2006-04-11 Baxter International Inc. Processing set for processing and treating a biological fluid
US7445756B2 (en) * 1999-06-03 2008-11-04 Fenwal, Inc. Fluid processing sets and organizers for the same
US7068361B2 (en) 1999-06-03 2006-06-27 Baxter International Apparatus, systems and methods for processing and treating a biological fluid with light
US6565802B1 (en) 1999-06-03 2003-05-20 Baxter International Inc. Apparatus, systems and methods for processing and treating a biological fluid with light
RU2411959C2 (ru) * 2004-06-29 2011-02-20 Релайанс Лайф Сайенсиз Пвт Лтд Способ получения безопасных в вирусном отношении биологических текучих сред
AU2005302256B2 (en) 2004-10-29 2011-01-20 Cerus Corporation Improved quenching methods for red blood cell inactivation process
KR101397386B1 (ko) 2005-12-13 2014-05-26 엑스테라 메디컬 코퍼레이션 혈액으로부터 병원성 미생물, 염증 세포 또는 염증단백질의 체외 제거를 위한 방법
CA2635628C (en) 2006-01-05 2013-05-07 Saint-Gobain Performance Plastics Corporation Annular seal and pump including same
WO2007082110A1 (en) 2006-01-05 2007-07-19 Saint-Gobain Performance Plastics Corporation Composite material and seals formed thereof
CA2720824C (en) 2008-04-09 2021-09-14 Cerus Corporation Improved quenching methods for red blood cell pathogen inactivation
DE202008012267U1 (de) * 2008-09-16 2009-02-05 KBD Gesellschaft für Unternehmensberatung, Marketing und Vertrieb mbH i. Gr. Vorrichtung zum visuellen Erkennen der Verteilung von lumineszierenden Substanzen
US8686175B2 (en) 2008-12-16 2014-04-01 Dow Corning Corporation Preparation of siloxanes
EP2379919A4 (en) 2008-12-24 2014-08-06 Saint Gobain Performance Plast POLYMER MATERIALS AND SEALS THEREFORE FOR HIGH-PRESSURE PUMPS
US11864553B2 (en) 2009-10-23 2024-01-09 Fenwal, Inc. Methods and systems for providing red blood cell products with reduced plasma
ES2861359T3 (es) 2009-12-01 2021-10-06 Exthera Medical Corp Dispositivo para eliminar citoquinas de la sangre con polisacáridos inmovilizados en superficie
WO2012112724A1 (en) 2011-02-15 2012-08-23 Exthera Medical, Llc Device and method for removal of blood-borne pathogens, toxins and inflammatory cytokines
EP2861273B1 (en) 2012-06-13 2017-08-23 ExThera Medical Corporation Use of heparin and carbohydrates to treat cancer
US9414752B2 (en) 2012-11-09 2016-08-16 Elwha Llc Embolism deflector
US20140158604A1 (en) * 2012-12-12 2014-06-12 Jacques Chammas Platelet Storage Container
BR112015032134B1 (pt) 2013-06-24 2022-05-10 Exthera Medical Corporation Método de ligação em ponto de extremidade de uma manose não redutora a um substrato e esfera possuindo uma manose ligada em ponto de extremidade
US9910041B2 (en) 2013-07-12 2018-03-06 Emd Millipore Corporation Method of determining virus removal from a sample containing a target protein using activated carbon
BR112016009827B1 (pt) 2013-11-08 2021-10-26 Exthera Medical Corporation Método in vitro para concentrar patógenos infecciosos presentes em uma amostra biológica obtida a partir de um indivíduo sob suspeita de estar infectado com os ditos patógenos, concentrador e kit
EP3134146B1 (en) 2014-04-24 2024-12-25 ExThera Medical Corporation Method for removing bacteria from blood using high flow rate
US10842818B2 (en) 2014-07-23 2020-11-24 Cerus Corporation Methods for preparing platelet products
US10857283B2 (en) * 2014-09-22 2020-12-08 Exthera Medical Corporation Wearable hemoperfusion device
EP3204426B1 (en) 2014-10-10 2020-11-25 Cerus Corporation Compositions for use in treating viral hemorrhagic fever
EP3313418B1 (en) 2015-06-26 2024-03-13 Cerus Corporation Cryoprecipitate compositions and methods of preparation thereof
US20170028121A1 (en) * 2015-07-31 2017-02-02 Fenwal, Inc. Irradiation device for biological fluids
CA3003097A1 (en) 2015-10-23 2017-04-27 Cerus Corporation Plasma compositions and methods of use thereof
IL260393B2 (en) 2016-01-07 2024-06-01 Cerus Corp Systems and methods for preparation of platelets
WO2017151797A1 (en) 2016-03-02 2017-09-08 Exthera Medical Corporation Method for treating drug intoxication
US11911551B2 (en) 2016-03-02 2024-02-27 Exthera Medical Corporation Method for treating drug intoxication
CA3055203A1 (en) 2017-03-03 2018-09-07 Cerus Corporation Kits and methods for preparing pathogen-inactivated platelet compositions
AU2018338097B2 (en) 2017-09-20 2023-07-13 Cerus Corporation Compositions and methods for pathogen inactivation of platelets
AU2018395525B2 (en) 2017-12-29 2023-09-14 Cerus Corporation Systems and methods for treating biological fluids
WO2020231830A1 (en) 2019-05-16 2020-11-19 Exthera Medical Corporation Method for modulating endothelial glycocalyx structure
US12011510B2 (en) 2019-06-22 2024-06-18 Cerus Corporation Biological fluid treatment systems
JP7571063B2 (ja) 2019-06-22 2024-10-22 シーラス コーポレイション 生物学的流体の処理を実施するシステム及び方法
CN114269394A (zh) 2019-06-28 2022-04-01 塞鲁斯公司 用于实现生物流体处理装置的系统和方法
WO2025264876A1 (en) 2024-06-20 2025-12-26 Cerus Corporation Systems and methods for pathogen inactivation of blood products

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE756082A (fr) * 1969-09-12 1971-03-11 I Elementoorganiche Kih Soedin Squelettes macroreticulaires de polystyrene pour resines echangeuses d'ions et leur procede de preparation (
US4748120A (en) * 1983-05-02 1988-05-31 Diamond Scientific Co. Photochemical decontamination treatment of whole blood or blood components
DE3819000A1 (de) * 1988-06-03 1989-12-14 Hasso Von Bluecher Beutel in der art eines teebeutels zur beseitigung von schadstoffen
US5094960A (en) * 1988-10-07 1992-03-10 New York Blood Center, Inc. Removal of process chemicals from labile biological mixtures by hydrophobic interaction chromatography
US5418130A (en) * 1990-04-16 1995-05-23 Cryopharm Corporation Method of inactivation of viral and bacterial blood contaminants
US5176634A (en) * 1990-08-02 1993-01-05 Mcgaw, Inc. Flexible multiple compartment drug container
US5209347A (en) * 1990-12-05 1993-05-11 Clintec Nutrition Company Internal tear seal dual bag
US5128048A (en) * 1991-05-22 1992-07-07 Baxter International Inc. Systems and methods for removing undesired matter from blood cells
ZA944488B (en) * 1993-06-23 1995-02-15 New York Blood Center Inc System for viral inactivation of blood
US5399719A (en) * 1993-06-28 1995-03-21 Steritech, Inc. Compounds for the photodecontamination of pathogens in blood
US6319662B1 (en) * 1993-12-17 2001-11-20 Baxter International Inc. Method and apparatus for removing viral contaminants from a body fluid

Also Published As

Publication number Publication date
CA2221605A1 (en) 1996-12-19
EP0840781B1 (en) 2009-12-09
CA2221605C (en) 2005-10-18
EP0840781A4 (en) 2001-03-21
EP0840781A1 (en) 1998-05-13
AU6267796A (en) 1996-12-30
JP2002509518A (ja) 2002-03-26
WO1996040857A1 (en) 1996-12-19
ATE451445T1 (de) 2009-12-15
JP4968974B2 (ja) 2012-07-04
DE69638094D1 (de) 2010-01-21

Similar Documents

Publication Publication Date Title
ES2337852T3 (es) Metodos y dispositivos para la eliminacion de psoralenos de productos sanguineos.
US6544727B1 (en) Methods and devices for the removal of psoralens from blood products
US20020192632A1 (en) Method and devices for the removal of psoralens from blood products
JP2002509518A5 (https=)
US20020115585A1 (en) Method and devices for the removal of psoralens from blood products
ES2434319T3 (es) Sistema y método para la reducción de los compuestos orgánicos pequeños de los hemoderivados
JP4473508B2 (ja) 生物的汚染物質を不活性化するための光増感物質を含む保存溶液
ES2282991T3 (es) Compuestos para la fotodescontaminacion de patogenos en la sangre.
JP2930595B2 (ja) 体組織中の感染性生物学的汚染菌の排除方法
EP2459248B1 (en) A novel method for microbial depletion in human blood and blood products using antimicrobial photodynamic therapy
ES2210846T3 (es) Nuevos psoralenos para inactivar agentes patogenos.
US6319662B1 (en) Method and apparatus for removing viral contaminants from a body fluid
ES2247587T3 (es) Procedimiento para la esterilizacion de composiciones biologicas y el producto producido mediante el mismo.
ES2972443T3 (es) Plasma pobre en crioprecipitado inactivado para patógenos y métodos de uso del mismo
JP2005511209A (ja) 病原体不活性化のために調整された血液成分を提供するための、手動の処理システムおよび方法
EP0773716A1 (en) Treating red blood cell solutions with anti-viral agents
CN107075478A (zh) 制备血小板制品的方法
Wagner et al. Approaches to the reduction of viral infectivity in cellular blood components and single donor plasma
JP2004520448A (ja) 酸化防止剤を使用するウイルスの不活性化法
JP2012067126A (ja) 血液製剤からソラレンを除去するための方法およびデバイス
AU757224B2 (en) Method and devices for the removal of psoralens from blood products
JP2009051846A (ja) 血液製剤からソラレンを除去するための方法およびデバイス
Ben-Hura et al. Pathogen Reduction in Blood for Transfusion Using Photodynamic
WO1996028025A1 (en) Inactivation of pathogens in blood and/or blood products using formaldehyde
BR112020005424A2 (pt) composições e métodos para inativação de patógenos de plaquetas